以色列 - 希伯来文 - Ministry of Health

novo nordisk ltd., israel - insulin degludec - תמיסה להזרקה - insulin degludec 200 u/ml - insulin degludec

以色列 - 希伯来文 - Ministry of Health

sanofi israel ltd - insulin glargine; lixisenatide - תמיסה להזרקה - lixisenatide 33 mcg / 1 ml; insulin glargine 100 units / 1 ml - insulin glargine

以色列 - 希伯来文 - Ministry of Health

sanofi israel ltd - insulin glargine; lixisenatide - תמיסה להזרקה - lixisenatide 50 mcg / 1 ml; insulin glargine 100 units / 1 ml - insulin glargine

以色列 - 希伯来文 - Ministry of Health

abic marketing ltd, israel - efavirenz; emtricitabine; tenofovir disoproxil as fumarate - טבליות מצופות פילם - efavirenz 600 mg; emtricitabine 200 mg; tenofovir disoproxil as fumarate 245 mg - emtricitabine, tenofovir disoproxil and efavirenz

以色列 - 希伯来文 - Ministry of Health

novo nordisk ltd., israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - treatment of diabetes mellitus.

以色列 - 希伯来文 - Ministry of Health

novo nordisk ltd., israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - treatment of diabetes mellitus.

以色列 - 希伯来文 - Ministry of Health

novo nordisk ltd., israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - treatment of diabetes mellitus.

以色列 - 希伯来文 - Ministry of Health

novo nordisk ltd., israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - treatment of diabetes mellitus.

以色列 - 希伯来文 - Ministry of Health

rafa laboratories ltd - treprostinil as sodium - תמיסה להזרקה - treprostinil as sodium 5 mg/ml - treprostinil - treprostinil - remodulin is indicated as a continuous subcutaneous infusion or intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders. pulmonary hypertension associated with congenital systemic to pulmonary shunts.

以色列 - 希伯来文 - Ministry of Health

rafa laboratories ltd - treprostinil as sodium - תמיסה להזרקה - treprostinil as sodium 2.5 mg/ml - treprostinil - treprostinil - remodulin is indicated as a continuous subcutaneous infusion or intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders. pulmonary hypertension associated with congenital systemic to pulmonary shunts.